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Insect olfactory receptors (ORs) are heteromeric ligand-gated cation channels
composed of a common olfactory receptor subunit (ORco) and a variable subunit
(ORx) of as yet unknown structures and undetermined stoichiometries. In this study,
we examined the allosteric modulation exerted on Anopheles gambiae heteromeric
ORx/ORco olfactory receptors in vitro by a specific class of ORco agonists (OAs)
comprising ORcoRAM2 and VUAA1. High OA concentrations produced stronger
functional responses in cells expressing heteromeric receptor channels relative to cells
expressing ORco alone. These OA-induced responses of ORx/ORco channels were also
notably much stronger than those obtained upon administration of ORx-specific ligands
to the same receptors. Most importantly, small concentrations of OAs were found to act
as strong potentiators of ORx/ORco function, increasing dramatically both the efficacy
and potency of ORx-specific odorants. These results suggest that insect heteromeric
ORs are highly dynamic complexes adopting different conformations that change in a
concerted fashion as a result of the interplay between the subunits of the oligomeric
assemblies, and that allosteric modulation may constitute an important element in the
modulation and fining tuning of olfactory reception function.
Keywords: Anopheles gambiae, mosquito olfaction, ligand discovery, ORco agonists, malaria, olfactory function
enhancement, olfactory receptor pharmacology, cell-based screening
INTRODUCTION
Insect odorant receptors (ORs) constitute a family of ligand-gated ion channels (Sato et al., 2008;
Wicher et al., 2008) unrelated to the mammalian olfactory receptors, which are members of the
G-protein coupled receptor (GPCR) superfamily (Touhara, 2002). They are heteromeric complexes
composed of a variable (ORx) and a conserved (ORco) subunit (Nakagawa et al., 2005; Neuhaus
et al., 2005; Sato et al., 2008), henceforth ORx/ORco, of as yet unknown stoichiometries. Their
study has received much attention both in the context of insect biology and evolution and the
potential for pest control applications (Leal, 2010; Carey and Carlson, 2011; Benton, 2015). Despite
the differences in olfactory receptor structure and signaling between insects and mammals (Kaupp,
2010; Silbering and Benton, 2010; Getahun et al., 2013), complexity in odor coding applies to
insects as much as mammals (Malnic et al., 1999; Hallem and Carlson, 2006).
One of the first insect OR repertoires to be studied due to its potential application for disease
vector control (Leal, 2010; Carey and Carlson, 2011), was that of the malaria vector Anopheles
gambiae, which was initially predicted to consist of 79 ORs [78 ORx members and ORco; (Hill
et al., 2002)]. Nearly half of them have been functionally characterized using the Xenopus oocyte
system (Wang et al., 2010), while up to 50 were functionally expressed in the empty neuron
system (Carey et al., 2010). Selectivity and recognition of odorant molecules is determined
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by the variable subunit (ORx), while ORco is essential for the
formation of the channel (Nichols et al., 2011). However, because
the structures of insect ORs have yet to be determined, the
properties of the odorant binding sites are basically unknown.
Moreover, the question on whether ORx, in addition to
recognizing the odorant molecules, is also contributing to the
formation of the pore is still open (Nakagawa et al., 2012).
Following the demonstration that ORco may form by itself
in vitro a functional ion channel gated by the synthetic agonist
VUAA1 (Jones et al., 2011), a number of related ORco agonists
(OAs) were generated and their effects on homomeric ORco
and heteromeric ORx/ORco channels assessed in various insects
(Jones et al., 2011; Bohbot and Dickens, 2012; Chen and Luetje,
2012; Romaine et al., 2014). OAs were found to activate the
ORx/ORco channels in the absence of odorant molecules (Jones
et al., 2011; Chen and Luetje, 2012) and were also reported to
synergize with odorant molecules and cause increased responses
(Jones et al., 2011; Bohbot and Dickens, 2012; Rinker et al.,
2012). However, the phenomenon of synergism between odorants
and OAs has not been sufficiently explored. Nevertheless, these
initial studies suggest that ORco may be a regulatory element of
heteromeric ORx/ORco channel function.
While the effects of OAs on insect physiology, behavior
and ecology have yet to be defined, their importance as tools
for elucidating pharmacological features of the ORx/ORco
channels is undisputed. Allostery is increasingly emerging
as a most important regulatory feature of protein function,
particularly from the viewpoint of impact on structure-function
relationships in complex oligomeric assemblies (Hogg et al., 2005;
Christopoulos et al., 2014; Langmead and Christopoulos, 2014),
especially in cases, such as those of insect odorant receptors,
where molecular structures are not available. From the different
forms of allosteric regulation (Laskowski et al., 2009), the most
common ones, pertinent to the present work, are those caused by
(i) binding of small molecule effectors, and (ii) protein-protein
interactions.
This study addresses issues related to allosteric regulation
of selected members of A. gambiae ORs mediated by specific
OAs belonging to the VUAA1/OrcoRAM2 family (Jones et al.,
2011; Bohbot and Dickens, 2012). It focuses on aspects of
allosteric modulation of ORco-dependent activity in the context
of different ORx/ORco heteromeric complexes and on differences
in ORx/ORco heteromer activation by cognate odorant ligands
in the presence of the same OAs. The findings of this study
are integrated into a model of proposed allosteric modulation
of odorant-gated olfactory channel function. The results may
also have implications for the development of new reagents for
enhancement of insect responses to various odorants.
MATERIALS AND METHODS
Chemicals
Odorants and OAs used in the current study are summarized in
Supplementary Table S1. Linalool, hexanoic and octanoic acid,
nonanal, and isoamyl alcohol were kind gifts from our colleagues
in NCSR Demokritos, Drs Maria Konstantopoulou, D. Tsiourvas
and G. Voutsinas. The OA VUAA1, used in preliminary
experiments, was a generous gift of Professor R. D. Newcomb,
New Zealand Institute for Plant & Food Research. Coelenterazine
was obtained from different vendors: Promega, BIOMOL GmbH
(Hamburg, Germany), Biosynth (Staad, Switzerland), and Carl
Roth GmbH (Karlsruhe, Germany), while Triton X-100 was from
Panreac. Initial stock solutions and dilutions for ORcoRAM2
were made in DMSO, while all remaining chemicals were
diluted in methanol or ethanol. Working dilutions were freshly
prepared immediately before use in modified Ringer buffer
(190 mM KCl, 25 mM NaCl, 3 mM CaCl2, 3 mM MgCl2,
20 mM Hepes, 22.5 mM glucose, pH 6.5), which reflects
more closely the composition of sensillum lymph (Kaissling
and Thorson, 1980; Grünert and Gnatzy, 1987; Olsson and
Hansson, 2013). Relative to the previously used Ringer buffer at
pH 7.2 (Tsitoura et al., 2015), this buffer yielded much higher
responses, with considerably higher signal-to noise ratios and
retention of specificity, without adverse effects on cell viability
(Supplementary Figure S1).
Plasmids
The cDNAs encoding A. gambiae odorant receptors (Iatrou
and Biessmann, 2008) and the calcium photoprotein Photina
(Axxam SpA, Milan, Italy) were expressed in lepidopteran
insect cells by the plasmid vector pIE1/153A [for brevity
pEIA; (Lu et al., 1997; Farrell et al., 1998; Douris et al.,
2006)]. The construction and use of pEIA.OR1, pEIA.OR2,
pEIA.OR9, pEIA.ORco, and pEIA.Photina have been previously
reported (Tsitoura et al., 2010; Tsitoura et al., 2015). The
PCR amplification of the complete OR53 open reading
frame (ORF) from antennal cDNA preparations, obtained
as previously described (Iatrou and Biessmann, 2008), was
carried out using forward and reverse primers OR53-FA/C
[GAATGGATCCCACCATGAAGTTACTAGAGCTAGACAAC]
and OR53-RA/N [GATAGGATCCTTAGAATACATTTTTTAGC
ACCAAG], respectively, (BamHI restriction sites are in italics,
initiation codon is in bold and termination codon is underlined).
This was followed by subcloning in the BamHI site of the
pEIA vector as previously described (Douris et al., 2006;
Tsitoura et al., 2010). Modified versions of pEIA (Douris
et al., 2006) were used for N-terminal tagging of ORco
with the FLAG epitope [(M)DYKDDDDK] (Tsitoura et al.,
2010) and ORs 1, 2 (Tsitoura et al., 2010), OR9 and OR53
with the Myc epitope [(M)EQKLISEEDL]. For the Myc-
tagged versions of OR9 and OR53 forward amplification
primers GAATGGATCCGTTAGGCTTTTCTTCAGCAAAAC
and GAATGGATCCAAGTTACTAGAGCTAGACAACC,
respectively were employed with the reverse amplification
primers used for the cloning of the authentic forms. All cloned
sequences were determined upon initial cloning and also
following their subcloning into the expression vector to ensure
lack of nucleotide substitutions or other mutations arising from
secondary PCR amplifications.
Cell Culture and Transfection
Trichoplusia ni BTI-Tn 5B1-4 HighFiveTM cells (henceforth Hi5;
Fisher Scientific) were used in the current study. The cells
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were grown in IPL-41 insect cell culture medium (Genaxxon
Bioscience GmbH) with 10% fetal bovine serum (Sigma or
Biosera) and maintained at 28◦C. Transfection was performed
with Escort IV (Sigma) or Biotool DNA transfection (Biotool)
reagents, using 2 µg of total plasmid DNA and 6 µg
of reagent per 106 cells, according to the manufacturer’s
instructions.
Expression of Mosquito ORs and
Bioluminescence Assays
The expression of A. gambiae ORs in lepidopteran insect cells
and their functional characterization by luminescence assays have
been previously reported (Tsitoura et al., 2010, 2015). Briefly,
Hi5 cells were transfected with pEIA.ORx, ORco and Photina
at per weight ratios (essentially molar ratios as well) of 1:1:2,
or with pEIA.ORco and Photina or pEIA.ORx and Photina
at 1:1. Cells were collected 2–4 days post-transfection, washed
and resuspended in Ringer solution, after which coelenterazine
was added at 5 µM and cells transferred to 96-well plates
(200,000–300,000 cells/well) and incubated at RT in the dark
for a minimum of 2 h. The Infinite M200 microplate reader
(Tecan Group Ltd) was used for measuring luminescence, before
and after application of odorants and OAs. Each experiment
was performed in triplicates, and was repeated in independent
experiments, as indicated for each figure. Results are presented as
means± standard deviation.
ORco Agonism and Allosteric Modulation
To study direct agonism, the OA ORcoRAM2 or, in some cases,
VUAA1, as exemplified in Supplementary Figure S2, was applied
to cells expressing ORco alone, or the different ORx/ORco
heteromers, or ORx alone (as negative controls), either at
100 µM or at increasing concentrations for the dose-dependent
experiments. In some experiments that required comparisons
of absolute values (i.e., magnitude of responses) between
different heteromers and the ORco homomer, normalization
for differences in transfection efficiencies and cell numbers
was performed by permeabilizing cells with Triton X-100
detergent (up to 0.15%), or by measuring intracellular Ca2+-
release responses in cells co-expressing a delta opioid receptor
together with Gα16, following administration of its ligand
DPDPE as previously described (Tsitoura et al., 2015). In
such case, cells expressing ORco homomers or ORco/ORx
heteromers were challenged sequentially with OA and TX100
in a separate series of wells, in order to avoid artifacts
from desensitization and responses were calculated as ratios
of OR response/TX100-evoked increase in luminescence. The
same was the case for co-expression with the delta opioid
receptor, except that the delta opioid receptor agonist DPDPE
was used instead of TX100 and responses were normalized
as OR response/opioid receptor response. To study the
synergistic effect of OAs and odorants, 5–10 µM concentrations
of ORcoRAM2 or VUAA1 were applied before, after or
simultaneously with a chosen concentration of odorant of
interest, and responses were measured in the microplate
reader.
Data Analysis and Curve Fitting
Data acquisition was performed with i-Control 1.3 (Tecan). As
before (Tsitoura et al., 2015), luminescence value comparisons
between independent experiments were made relative to
normalization standards. Thus, the specific agonist (odorant
or OA) at highest concentration or both (for potentiation
experiments) were considered to cause 100% (maximal)
response for the specific set of experiment. For curve
fitting and EC50 calculations (expressed also in the form of
the negative logarithm of the EC50, pEC50, which gives a
commensurate measure of potency), GraphPad Prism 4.01
was used. Specifically, concentration-response data were
fitted to the equation for non-linear regression, sigmoidal
dose-response (variable slope): Y = Bottom + (Top –
Bottom)/(1 + 10ˆ(LogEC50 – X)*Hillslope), where Y : %
response at a given concentration; X: logarithm of concentration,
with Top and Bottom values being the maximal and minimal %
responses and the following constraints being applied: bottom
>0.0 and Top <100.0. Each independent experiment was
performed in triplicate wells, with the number of repetitions
indicated for each graph. Statistical analysis was one-way
ANOVA followed by Bonferroni’s multiple comparison
test.
Antibodies and Western Blot Analysis
Expression of ORs by western blot analysis was essentially as
previously described (Tsitoura et al., 2010). In particular, Myc-
tagged ORs 1, 2, 9, and 53 were detected in total lysates of
transiently transfected Hi5 cells, by the use of mouse anti-Myc
antibody (Cell Signaling 9B11, 1:1,000 dilution). For Flag-tagged
ORco protein detection in cells expressing either ORco (fORco)
alone or its combinations with various ORx subunits, the
anti-Flag antibody (Sigma F1804, 1:800 dilution) was used. In the
latter case, Hi5 cells were transfected with constructs directing
expression of fORco, OR1/fORco, OR2/fORco, OR9/fORco or
OR53/fORco and Photina, and cells were used for western blot
analysis and, in the presence of co-expressed Photina, functional
assays.
Sequences and Predictions
The sequencing of the clones for the OR9 and OR53 receptor
subunits, which were employed in this study, revealed differences
from their previously reported counterparts (VectorBase
IDs AGAP008333-PA and AGAP009390-PA, respectively).
These consisted of segmental insertions of 9 and 8 amino
acids, respectively (NCBI Accession numbers KX697339 and
KX697340, respectively). These were apparently produced as a
result of differential splicing of the respective primary transcripts,
which gave rise to the specific mRNAs shown in Supplementary
Figures S3A,C, respectively. The segmental insertions were
predicted to reside in the corresponding second intracellular
and second extracellular loops (Supplementary Figures S3B,D,
respectively). Transmembrane (TM) domain predictions for
OR9 and OR53 were made using the TMpred program2 and
1graphpad.com
2ch.embnet.org
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TOPCONS3 (Tsirigos et al., 2015), and the schematic drawings
in Supplementary Figures S3B,D (right) were generated based
on results from the latter. Predicted TM topologies for OR53
(TOPCONS) were 33–53, 68–83, 123–143, 174–194, 252–272,
281–301, 354–374. For OR9, six TM regions were predicted
with most TOPCONS sub-methods used. The OCTOPUS and
SPOCTOPUS sub-methods, however, predicted seven TM
domains at 56–76, 87–107, 148–168, 192–222, 288–308, 319–339,
389–409 with the last one being predicted only by these two
algorithms.
RESULTS
ORco Agonist-Induced Activation of
Olfactory Receptor Heteromers
The effects of OAs on the function of A. gambiae olfactory
receptor heteromers were examined in lepidopteran insect cells
expressing either ORco or different ORx/ORco heteromers
and the reporter photoprotein Photina, as previously described
(Tsitoura et al., 2015). Four ORx subunits were tested in
this study, OR1, OR2, OR9, and OR53, all displaying high
female antenna-biased expression (Iatrou and Biessmann, 2008).
OR1 and OR2 have been selected as specialist receptors
responding to chemicals of great importance for mosquito
physiology, including oviposition cues and components of
human sweat (Hallem et al., 2004; Carey et al., 2010; Wang
et al., 2010). OR9 and OR53, on the other hand, were used
as examples of other deorphanized receptors that displayed
notably lower responses in various functional assays (Carey
et al., 2010; Wang et al., 2010). Indicatively, in the Xenopus
system, response magnitudes of 100–150 were reported for
OR9 and OR53 against their cognate ligands, while by
comparison, response magnitudes of OR2 and OR4 against
their ligands were up to 600 and those for OR10 and
OR28 were in the range of 3000–4000 (Wang et al., 2010).
Although functionally analyzed to a limited extent, these latter
receptors have not been subjected to detailed pharmacological
characterization.
The functionality of ORco homomers and OR1/ORco and
OR2/ORco heteromers with their ligands in the specific insect
cell-based assay has been demonstrated previously (Tsitoura
et al., 2015). The OR9 and OR53 isoforms employed in
this study (Supplementary Figure S4) were also found to be
functional in the same assay. Thus, the OR9/ORco heteromeric
receptor responded to 2-ethylphenol and to a much lesser
extent to 4-methylphenol and 3-methylphenol (Supplementary
Figure S4A, left), in agreement with the previously established
odorant selectivity (Carey et al., 2010; Wang et al., 2010).
For 2-ethylphenol, a dose response analysis revealed an EC50
of approximately 78 µM (Supplementary Figure S4A, right;
Table 1). On the other hand, the OR53/ORco receptor was
functionally tested with a number of odorants that were selected
based on previous studies, which reported functional responses
in either the Xenopus oocyte or the Drosophila empty neuron
3http://topcons.cbr.su.se
models (Carey et al., 2010; Wang et al., 2010), while keeping in
mind that some of these chemicals yielded contradictory results
in the two systems. From the tested chemicals, we obtained
clear responses only with linalool (Supplementary Figure S4B),
a compound related to linalool oxide, which was reported to be
slightly active against this receptor in the empty neuron system
(Carey et al., 2010). The responses to linalool were found to be
dose-dependent (data not shown), however, its EC50 at∼180 µM
was comparable to those of OR1 and OR2 partial agonists in
this system, 3-methylphenol (for OR1/ORco) and benzaldehyde
and 2-methylphenol (for OR2/ORco) (Tsitoura et al., 2015
and data not shown). Nevertheless, additional functional assays
described below established firmly the functionality of this
receptor.
To investigate the effects of OAs on the different odorant
receptor heteromers, we examined the functional responses of
lepidopteran cells expressing the respective receptor subunits
upon addition of VUAA1 or OrcoRAM2, both of them members
of the first reported class of OAs. As shown in Figure 1A,
unequivocal responses, in terms of Ca2+-ion entry, could be
detected in cells expressing ORco homomers and its heteromers
with OR1, OR2, OR9, and OR53 upon treatment with 100 µM
of OrcoRAM2, a concentration equal to the EC50 for ORco
(Table 1).
For three of the four ORx/ORco receptor heteromers
examined, the responses triggered by the OA were more robust,
on average 3 to 4-fold (Figure 1A; Supplementary Table S2),
than those observed in cells expressing ORco alone (Figure 1A),
even though the latter contained nearly double the amount of
ORco relative to cells expressing each heteromer due to respective
differences in ORco expression vector quantities transfected into
the cells (Figure 1B, left). OR9 was the only ORx not to conform
to this observation but this may have been due to a consistently
lower quantity of receptor expressed in the transfected cells, at
least relative to OR2 and OR53; additional factors, however, may
account for this, as levels of OR9 expression are quite similar with
those of OR1 (Figure 1B, right). Importantly, the efficacies of the
responses of the tested receptors to the specific dose of OA were
also strikingly higher than those observed with an equivalent
concentration (100 µM) of ORx-specific agonists (Figure 1C).
This concentration of ORx-specific ligands (SLs) represented a
range of EC values [nearly EC90 for 4-methylphenol and indole
against OR1 and OR2, respectively (Tsitoura et al., 2015); EC60 for
2-ethylphenol against OR9 (Supplementary Figure S4A; Table 1);
and ∼EC18 for linalool against OR53 (Table 1)]. The latter
increases in receptor heteromer response efficacies ranged from
6-fold to 10-fold for three of the four tested receptor heteromers
(those of OR1, OR2, and OR9), while for the OR53 heteromer
the response to the OA was more than 100 times more efficacious
than linalool (Figure 1C; Supplementary Table S2). Considering,
however, that 100 µM of linalool, which is a partial OR53 agonist,
represented only an ∼EC18 value for OR53, the latter difference
was not unexpected. However, the observed enhanced efficacy
of the OA versus the odorant is maintained or even increased,
when concentrations of OA and odorants are adjusted for each
receptor heteromer, to be more close to equipotency (as shown
for representative OR members in Supplementary Figure S5).
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TABLE 1 | EC50 values from concentration-dependent response curves.
Receptor Chemical EC50 (pEC50 ± SE) R2 Reference
OR1+ORco OA 56.6 µM (4.247 ± 0.05688) 0.9831 Figure 2
4MP 2.8 µM (5.548 ± 0.1984) 0.9416 Tsitoura et al., 2015
1.2 µM (5.927 ± 0.03852) 0.9961 Figure 4
4MP+OA 104.6 nM (6.981 ± 0.2329) 0.9772 Figure 4
OR2+ORco OA 43.6 µM (4.361 ± 0.02894) 0.9903 Figure 2
IN 3.4 µM (5.465 ± 0.1186) 0.9829 Tsitoura et al., 2015
5.5 µM (5.258 ± 0.03010) 0.9865 Figure 4
IN+OA 52.5 nM (7.280 ± 0.1809) 0.9667 Figure 4
OR9+ORco OA 78.7 µM (4.104 ± 0.01060) 0.9973 Figure 2
2EP 77.6 µM (4.110 ± 0.009062) 0.9992 Figure 4; Supplementary Figure S4
2EP+OA 6.1 µM (5.213 ± 0.08414) 0.9845 Figure 4
OR53+ORco OA 56.6 µM (4.247 ± 0.03210) 0.9906 Figure 2
LIN (partial agonist) 181.1 µM (3.742 ± 0.04453) 0.9944 Figure 4
LIN+OA 12.6 µM (4.899 ± 0.1493) 0.9800 Figure 4
ORco OA 58.9 µM (4.23 ± 0.034) 0.9655 Tsitoura et al., 2015
96.6 µM (4.015 ± 0.02398) 0.9863 Figure 2
Summarized are the EC50 values obtained from curves presented in Figures 2 and 4 and Supplementary Figure S4. For the four ORx/ORco heteromeric complexes
studied (with OR1, OR2, OR9, and OR53), the numbers presented here concern EC50 values of specific odorants (4MP, IN, 2EP, and LIN, respectively), ORco agonist
ORcoRAM2 (OA) and the specific combinations used in potentiation studies. EC50 values of OA for the homomeric ORco channels are also presented. EC50, half maximal
effective concentration; pEC50, negative logarithm of the EC50 (–logEC50); Std. error, standard error (SE) reported by GraphPad Prism for calculated logEC50; R2, measure
of goodness of fit. Previously obtained values for OR1/ORco (4MP), OR2/ORco (IN), and ORco (OA) (Tsitoura et al., 2015) are also listed.
An OA dose response analysis for the studied receptor
heteromers showed that, similar to the case of the ORco
homomer, administration of low concentrations of OrcoRAM2,
in the order of 5–10 µM, to cells expressing the specific
heteromers produced only minimal, if any, responses
(Figure 2A). However, in the presence of slightly higher
concentrations of OA, in the order of 30 µM, ORx/ORco
heteromers yielded noticeably higher functional responses than
the ORco homomers (Figure 2A). Nevertheless, as shown in
Figure 2B; Table 1, the OA dose responses for OR1, OR2, OR9,
and OR53 heteromers revealed very similar OA potencies (EC50
values of 57, 44, 79, and 57 µM, respectively) relative to the ORco
homomers (EC50 of 59 and 97 µM in two independent studies;
Table 1).
These results suggest that the enhanced functional responses
of the tested ORx/ORco heteromeric channels relative to
ORco homomers upon OA administration are probably due
to conformational changes and consequential activity increases
induced on the ORco channel as a result of its association with
the specific ORx subunits. An alternative explanation invoking
increased stability of ORco or even enhanced partitioning on the
cell plasma membrane due to its association with ORx subunits in
the context of the heteromer as cause for the enhanced functional
responses of the heteromeric channels to the OA, cannot be
excluded without further experimentation.
Whether the interaction of ORco with ORx subunits results in
the generation of new channel pores formed with contributions
by both ORco and ORx, is not possible to deduce from these
results alone. Nevertheless, given the similarity of OA potencies
for ORco homomeric and heteromeric channels, the simplest
scenario would predict the existence of a common, ORco-
based channel pore whose structure and activity are regulated
by changes induced by the interactions with the different ORx
subunits. The fact that, for any given heteromer, the response to
the OA appears to be more efficacious than the response to each
specific odorant is also a significant finding as it suggests that
each heteromer can exist in different conformations leading to
differential functional outputs.
ORco Agonist Acts as Enhancer of ORx
Ligand-Induced Responses
To assess whether the presence of an OA may also affect the
ORx ligand-dependent responses, cells co-expressing different
heteromeric receptors were treated with 10 µM OrcoRAM2,
a concentration that is by itself essentially unable to trigger
substantial responses (Figure 2A), prior to or concurrently
with the addition of 100 µM of various ORx cognate
odorants.
As may be seen in Figure 3A, a very strong enhancement
in specific odorant-induced responses was obtained from cells
treated with the low concentration of OA relative to the
responses obtained in its absence. The relative increases in
response magnitudes ranged from 5 to more than 30-fold
for the receptors with known agonists (OR1, OR2, and OR9;
Supplementary Table S2). The potentiation of the receptors’
responses by 10 µM OA, at equipotent, EC20, concentrations of
odorants for the different heteromers, was also strong, ranging
from 10 to almost 95-fold (Supplementary Figure S6). On
the other hand, the responses of the cells to the partial ORx
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FIGURE 1 | Direct agonism of heteromeric and homomeric OR receptor function by ORco agonists (OAs). Results of experiments employing OrcoRAM2
as an OA are shown. (A) Magnitude of responses obtained from cells expressing ORco, OR1, OR2, OR9, OR53 alone or the same ORx subunits as heteromers with
ORco, in the presence of 100 µM of the OA. (n = 2 for OR9, OR53, and OR53/ORco; 3 for OR1, OR2, OR9/ORco; 6 for OR1/ORco, OR2/ORco, and ORco alone,
the latter being tested in all experiments). Positive responses only were assessed by one-way ANOVA, followed by Bonferroni’s multiple comparison test, and
significances of each heteromer’s response relative to ORco are depicted: ∗∗P < 0.01; ∗∗∗P < 0.001. (B) Left. Detection of ORco by western blot analysis in cells
expressing ORco homomeric or ORx/ORco heteromeric complexes. Flag-tagged version of ORco was used in this experiment, and detection was performed by
monoclonal antibody against the Flag epitope. Right. Detection of expression of ORs 1, 2, 9, and 53. Myc-tagged versions of ORx subunits were used in this
experiment, and detection was performed by monoclonal antibody against the Myc epitope. The mock sample contains lysates from untransfected cells.
(C) Comparison of the magnitudes of the heteromers’ responses to their specific ligands (SLs) (4MP for OR1, IN for OR2, 2EP for OR9, and LIN for OR53) relative to
those obtained with the OA, both applied at a concentration of 100 µM. The inset in the bargraph for OR53 presents more clearly the low response of the cells that
express the OR53/ORco heteromer to the partial agonist LIN (n = 3, 6, 4, and 2 for ORs 1, 2, 9, and 53, respectively).
agonists, 3-methylphenol (for OR1), benzaldehyde (for OR2),
3- and 4-methylphenol (for OR9) and linalool and octanoic
acid (for OR53) [(Wang et al., 2010; Tsitoura et al., 2015); and
Supplementary Figure S4A] were also enhanced considerably by
the addition of the low concentration of OA. However, relative
to the respective best agonists, the OA-induced potentiation
of partial agonist responses was distinctly lower (Figure 3B).
A possible qualification for this conclusion concerns OR53, for
which a 140-fold enhancement was observed (up to 250 for
the EC20 concentration of linalool, Supplementary Figure S6),
because the best cognate ligand for this receptor has yet
to be determined and, therefore, a direct comparison could
not be made. Importantly, no activity induction by the low
concentration of the OA was obtained with compounds that do
not normally activate ORx/ORco receptors (Figure 3C). We also
note that the OA-induced potentiation of responses occurred
irrespective of the order of addition of the OA to the cells
relative to the administration of the ORx agonists (data not
shown).
These results suggest that although the OA augments the
responses of the ligand-gated OR channels to their physiological
agonists, it does not alter the existing affinity differences between
agonists. Two notable exceptions to this rule were the cases
of indole for OR1 and octanoic acid for OR53, which yielded
responses in the presence of the low OA concentration despite
the fact that they did not act as specific agonists, even partial
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FIGURE 2 | Dose-dependent agonism of heteromeric receptor function by OAs. (A) Functional responses of cells expressing ORco alone or OR1/ORco,
OR2/ORco, OR9/ORco, and OR53/ORco heteromers to increasing concentrations of OrcoRAM2. Results shown are from 3 to 4 independent experiments, each
performed in triplicates; the responses for each receptor are normalized to the highest one (100%) obtained with 200 µM of the OA. (B) Comparison of the pEC50
values for ORco homomer and the four studied heteromers (∗∗P < 0.01; ∗∗∗P < 0.001, for each heteromer relative to ORco).
ones, in our system. For OR1, the lack of indole recognition
has been documented in all testing systems used for functional
characterization (Xia et al., 2008; Carey et al., 2010; Wang et al.,
2010; Tsitoura et al., 2015). For octanoic acid, activity against
OR53 has been shown in Xenopus oocytes (Wang et al., 2010)
but not the Drosophila empty neuron system, where it was
found to be inactive (Carey et al., 2010), or our system (up to a
concentration of 100 µM; Supplementary Figure S4B). Whether
these chemicals may activate partially the respective receptors at
higher concentrations in insect cell-based system has not been
examined.
To obtain a more detailed assessment of the potentiation
of olfactory receptor responses by the low concentration of
the OA, dose response curves were constructed for the specific
ligands (SLs). As shown in Figure 4, the presence of OrcoRAM2
caused a notable, ORx ligand-dependent enhancement in the
functionality of the heteromeric receptors of known odorant
ligand recognition both in terms of efficacy and potency.
Specifically, while the increases in response magnitudes of the
tested receptors ranged from 6-fold to 32-fold (and 141-fold
relative to linalool for OR53) (Figure 4A; Supplementary Table
S2), the potency increases (decreases in EC50 values) ranged
from 12-fold to more than 100-fold (Figure 4B; Table 1).
The shifts of the curves, as well as the concomitant potency
changes in EC50 values were intermediate when a lower
concentration (1 µM) of OA was used instead of 10 µM (data
not shown).
Collectively, these results provide support to the notion
that OAs, even when present at low concentrations, induce
allosteric changes to odorant-gated heteromeric receptor channel
structures resulting in significant positive modulation of
responses to specific odorants. These allosteric changes appear to
be also ORx ligand-dependent.
DISCUSSION
ORco, the insect olfactory co-receptor, is steadily becoming the
focus of attention because of discoveries linking its functionality
to new insights into the function of olfactory receptors and new
directions in olfaction-based approaches for insect pest control.
Its importance has been already documented, mainly through
studies employing specific RNAi to suppress ORco expression (Yi
et al., 2014; Zhou et al., 2014; Fan et al., 2015; Lin et al., 2015;
Franco et al., 2016; Zhang et al., 2016) or complete elimination of
Orco via genome editing (DeGennaro et al., 2013; Koutroumpa
et al., 2016). Additionally, we have previously established that
a series of strong mosquito repellents act as ORco antagonists
that cause the in vitro blocking of specific odor recognition
by olfactory receptors requiring its presence for functionality
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FIGURE 3 | OAs act as allosteric enhancers of heteromeric receptor function. (A) Cells expressing OR1/ORco, OR2/ORco, and OR9/ORco were challenged
with 100 µM of their specific agonists (4MP, IN, and 2EP, respectively) in the absence (–) or presence (+) of a low concentration (10 µM) of OA (ORcoRAM2).
OA-dependent potentiation was observed for all three tested heteromers (n = 5, 6, and 3, respectively). (B) Potentiation of responses to 100 µM of partial agonists
(3MP for OR1/ORco, BA for OR2/ORco, 3MP and 4MP for OR9/ORco, and LIN for OR53/ORco) by 10 µM of the OA. Individual application of odorants alone is
depicted by – signs, while the combined application of the OA and odorants is indicated by + signs (n = 2 for ORs 1, 2, and 9; n = 5 for OR53). (C) Lack of
measurable potentiation by cells expressing OR1, OR2, OR9, and OR53 heteromers with ORco upon administration of odorants that do not normally activate these
receptors and a low concentration (10 µM) of the OA. In all experiments, the SLs (4MP for OR1, IN for OR2, 2EP for OR9, and the partial agonist LIN for OR53) were
used as positive controls providing maximal (100%) OA-potentiated responses (n = 3 for OR1 and OR2; 2 for OR9; and 3–5 for OR53). The cases of IN (for OR1)
and OCT (for OR53), which appear as apparent exceptions to the behavior of odorants not recognized by the respective receptor heteromers are discussed in the
main text (significance of OA+IN relative to OA and OA+OCT relative to OA for OR1 and OR53, respectively, is depicted: ∗P < 0.05).
(Tsitoura et al., 2015). Moreover, several other compounds were
also shown to be capable of inhibiting insect odorant receptor
function through antagonism of the co-receptor subunit (Chen
and Luetje, 2012; Jones et al., 2012; Chen and Luetje, 2013; Pask
et al., 2013; Chen and Luetje, 2014). In the current report, we
present results suggesting that OAs may be also used as agents
that enhance the odor recognition sensitivity of the mosquito
olfactory system.
The finding that ORco may act as a ligand-gated channel
in the absence of ORx subunits (Jones et al., 2011) has
been a major discovery for the field. However, the question
of whether ORco homomers may actually exist in olfactory
receptor neurons remains unanswered. Should ORco homomers
and ORx/ORco heteromers co-exist in olfactory receptor
neurons and assuming that natural OAs also exist that act
on ORco in the same fashion as VUAA1 and OrcoRAM2,
based on the in vitro results presented here (Figure 1A)
we would predict that the heteromeric channel responses
to them would be considerably stronger than those of
any co-existing ORco homomeric channels. Therefore, the
overall response profiles of the heteromeric population should
not be influenced significantly by any co-existing ORco
homomers.
Because of their large size and essential lack of volatility, the
available synthetic OAs (Chen and Luetje, 2012; Romaine et al.,
2014), including those used in the current study, may not be of
physiological relevance. Nevertheless, they constitute useful tools
for the pharmacological characterization of olfactory receptors.
For example, they may be used, as was shown in this study, for
activity comparisons between ORco homomers and ORx/ORco
heteromers, as well as direct pharmacological comparisons of
different ORx/ORco heteromers without interference from effects
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FIGURE 4 | The OA is an allosteric modulator that enhances both the affinity and efficacy of odorant recognition by cognate olfactory receptors
in vitro. (A) Upward and leftward shifts of the dose-response curves of OR1, OR2, OR9, and OR53 heteromers with ORco, to their SLs 4MP, IN, 2EP, and (partial
agonist) LIN, respectively, in the presence of a low concentration of OA (10 µM). The upper and lower panels present the same results with different types of
normalization: in the upper panels, the responses for each receptor were normalized relative to the highest responses (100%) obtained with each SL in the presence
of 10 µM of the OA (SL+OA); while in the lower panels, the responses for each receptor were separately normalized to the maximum value (100%) obtained at the
highest concentration of each SL alone or in the simultaneous presence of 10 µM of the OA (SL+OA) to make more evident the leftward shift. (B) Comparison of the
pEC50 values of the specific odorants alone or together with 10 µM of the OA (black and gray bars, respectively) for the four tested heteromers. The pEC50 values
(also listed in Table 1) are (mean ± SE): 4MP 5.927 ± 0.03852 and 4MP+OA 6.981 ± 0.2329 for OR1/ORco; IN 5.258 ± 0.03010 and IN+OA 7.280 ± 0.1809 for
OR2/ORco; 2EP 4.110 ± 0.009062 and 2EP+OA 5.213 ± 0.08414 for OR9/ORco; and LIN 3.742 ± 0.04453 and LIN+OA 4.899 ± 0.1493 for OR53/ORco. (n = 2
for OR1/ORco and OR9/ORco, 3 for OR2/ORco and OR53/ORco).
exerted by specific ORx ligands. In this context, the first
major finding of this study has been that in the absence of
ORx cognate ligands, relatively high concentrations (100 µM)
of the specific OA ORcoRAM2 trigger, in most examined
cases, heteromeric channel responses whose magnitudes are
noticeably higher than those of the ORco channels (Figure 1;
Supplementary Table S2) essentially without major concomitant
changes in agonist potencies (Figure 2; Table 1). Both of these
findings may be explained by the induction of differential
conformational changes on ORco homomeric channels caused
by the interacting ORx subunits. Alternative explanations,
however, cannot be excluded in the absence of further
experimentation. For example, it is conceptually possible that the
association of ORco with ORx subunits results in an increased
stability of heteromeric complexes relative to homomeric
ones or even increased partitioning on the cellular plasma
membrane.
A second important finding, shown for all combinations
studied here, has been that the specific OAs synergize with ORx-
SLs and act as positive allosteric modulators of heteromeric
channel function. The potentiation of responses obtained in vitro
from the olfactory channels upon administration of ORx-SLs in
the presence of low concentrations of an OA had been noted
previously (Jones et al., 2011; Bohbot and Dickens, 2012) but not
studied in detail. The conformational changes that apparently are
induced by the OA on the heteromeric agonist-gated complexes,
even at the low concentration of 10 µM employed in our study,
which by itself provides no or only minor functional competence
to homomeric and heteromeric channels in vitro (Figure 2),
account for the increases in both the response magnitudes evoked
by the specific ORx agonists and their potencies (Figure 4).
Interestingly, the potentiation exerted by the OAs on ligand-gated
olfactory channel responses appeared to leave the fundamentals
of ORx-ligand recognition specificity and function essentially
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unaltered, with highly potentiated responses obtained with the
most potent agonist for any given receptor, somewhat lower
responses achieved with less potent agonists, and no potentiation
occurring with chemicals that do not activate the tested receptors
(Figure 3). Based on the combined results of potentiation, we
suggest that the use of low concentrations (10 µM or lower)
of OAs in ligand screening programs may provide significant
advantages both in terms of enhancement of responses that
are at the threshold of detection and capacity to use lower
concentrations of the screened compounds. In this regard, we
note that in addition to the 10 µM OA concentration that we
have presented and discussed here, we have also seen potentiation
with 1 and 5 µM of ORcoRAM2 (data not shown). In view of
the current paucity in our knowledge concerning the molecular
structure of insect olfactory receptors, the results of this study also
provide tantalizing suggestions concerning the modulation and
certain mechanistic aspects of the activation of the heteromeric
channels by odorants, OAs or both, and these are summarized
in Figure 5. In this regard, a consideration of anticipated basic
features of the homomeric and heteromeric OR channels may be
instructive. Starting from ORco (Figure 5A), while the channel
remains impermeable to ions in the absence of OA (non-
aligned, brown rectangular subunits), a “channel on-channel
off” (incomplete agonist occupation; brown hexagon) situation
resulting from transient changes in the structure of the homomer
(illustrated by the change from a rectangular to an oval-shaped
subunit in Figure 5A), should exist at agonist concentrations 10-
fold lower than EC50 (brown hexagon). These, apparently result
in very low net influx of cations into the cells through the pore
(arrow 1). In the presence of OA concentrations approaching or
FIGURE 5 | Models of ORco homomeric and ORx/ORco heteromeric channels and schematic overview of allosteric modulation by OAs. Channel
subunits are indicated by rectangular or oval shapes of different colors (brown for ORco and green for ORx), with conformational changes induced on subunits as a
result of ORco or ORx-specific agonist binding being indicated by changes in shape (from rectangular to oval) and channel pore openings of various sizes induced by
different ligands indicating magnitudes of ion permeability. ORco and ORx ligands are indicated by brown hexagons and green triangles or green ellipsoids,
respectively, inside the corresponding receptor subunits. For all cases, conformational changes occurring in any given channel subunit have notable effects on the
structure of its interacting subunit due to altered protein-protein interactions, and induce changes in magnitudes of ion permeability indicated by commensurate
changes in channel pore sizes. (A) ORco channel: the different states of the homomeric ORco channel, which is presented here as a dimer, are shown with the
unliganded, inactive state indicated by misaligned subunits and a closed pore, and the partially (+OA left) or fully active (+OA right) states indicated with the partly or
fully changed shapes of one or both channel subunits, depending on agonist concentrations, alignment of channel subunits and commensurately increasing pore
widths. Arrow 1 indicates the final effect of ligand gating on the channel pore. (B) ORx/ORco channel: the different states of the heteromeric channels (ORx/ORco
channel) are shown, with dimers and tetramers illustrated for simplicity. Schematic in (I) shows heteromers containing an ORco-based channel pore, while (II)
illustrates heteromers with the channel pore formed with contributions by both ORx and ORco subunits. For (I), a low concentration of the OA is indicated by a single
binding site per receptor complex (Ib, left), while ORco and ORx-specific agonist concentrations at or higher than EC50 are indicated by two bound agonists per
receptor complex (Ib, right, and Ia). In the case of (II), the high ORco or ORx agonist states are indicated with the respective ligands being highlighted with black
contour (IIb, right, and IIa), while the enhanced potency of the ORx agonist resulting from the simultaneous binding of the OA, observed under incomplete agonist
occupancy conditions, is indicated by the change of the ligand’s shape from triangle to ellipsoid and the presence of the black contour (IIc). Arrows 2 and 3 indicate
the effects of specific ORx ligands or the OAs, respectively, on channel pore permeabilities, while arrows 4 and 5 (with dotted lines) point to the elements on which
the OA is hypothesized to act and thus affect the nature of the binding pocket (potency) and efficacy, respectively, of the SL. Note that for reasons of figure clarity,
only one set of the predicted interactions is illustrated in the case of the high ligand concentration (Ic).
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exceeding the EC50 for ORco (100 µM; full agonist occupation
illustrated by brown hexagons in both subunits) [(Tsitoura et al.,
2015); Table 1], the “channel on” (full agonist occupation) state
should be favored, due to the stabilization of the structural
changes in the homomeric channel (transition to structure with
aligned oval subunits), which translate into increased rates of ion
influx through the pore.
For the heteromeric channels (Figure 5B, ORx/ORco
channel), two types of channel structure formation are envisaged
irrespective of stoichiometric considerations (for simplicity,
dimers and tetramers are illustrated for the heteromers in
Figure 5B but other configurations are, of course, possible).
Of the two possible alternatives, the first, which we consider
more likely, predicts the existence of a channel structure
analogous but not identical to that of the homomeric channel.
This is formed again by the ORco subunits alone (Figure 5B,
I), but its structure is affected (alignment of the brown
rectangular subunits) because of the interactions of ORco
with the ORx subunits (green rectangular subunits). The
second type of channel envisages the generation of completely
different type of channel pore formed with contributions from
both ORx and ORco partner subunits (Figure 5B, II). In
both cases, a positive regulatory role is predicted for the
unliganded ORx subunits via their interactions with ORco
and the induction of ORx-dependent changes to the ORco
subunit structure (illustrated by the subunit alignment in
Figures 5B, I and II). The latter, impact on the functional
potential of the respective heteromeric channels and the
permeability of their pores upon ligand addition, as well as
their differential responses to OAs; however, potential effects of
heterodimerization on stability and trafficking should also be
born in mind.
For the responses of heteromeric channels to ORx cognate
ligands, the binding of an ORx-SL to the ORx subunit (green
triangles in Figures 5B, Ia and IIa) is envisaged to induce
secondary, ORx subunit-mediated changes to the heteromeric
structure (transitions to oval-shaped subunits in Figures 5B, Ia
and IIa) contributing to the opening of the pore (arrow 2). For
the functional responses of heteromeric channels to the OA in
the absence of ORx cognate ligands (Figures 5B, Ib and IIb),
we suggest that they follow the same fundamental principles
noted for homomeric ORco channels but with the added feature
of the conformational changes in channel structure induced
by the interactions between ORx and ORco subunits, which
impact positively on the permeability of the pores (arrow 3) thus
causing an increase in OA efficacy relative to the homomeric
channel. A caveat to this hypothesis is the previously mentioned
possibility of stabilization or increased availability of ORco on the
cell membrane due to its association with ORx subunits in the
heteromeric complex.
For the potentiation of ORx ligand-gated heteromeric channel
function by low concentrations of OAs (Figures 5B, Ic and
IIc), we suggest that the allosteric changes effected on the
heteromeric channel subunits by their interactions and those
triggered by their respective agonists, synergize to cause a
further increase in the “opening” of the channel and the rates
of cation influx into the cells relative to the rates obtained
by the specific ORx agonists or the high concentrations of
OAs alone. Specifically, besides the allosteric effects discussed
above (indicated by the transition to the oval subunit shape
in Figure 5B), our results suggest that the binding of the
OA to the ORco subunit may also enhance allosterically the
binding of ORx-SL (arrow 4) by changing the properties of
its binding pocket (green oval-shaped ligands) causing an
increase in the potency and efficacy (arrow 5) of the ORx
ligand, the latter in terms of magnitude of pore permeability
induced by it. These postulates are compatible with the
observation that the OA leaves the fundamentals of ORx ligand
recognition specificity and function of the heteromeric channels
essentially unaltered, with the potentiation of responses being
proportional to the “native” (SL-induced) strength of the channel
(Figure 3). For the synergistic action and activity changes
induced upon simultaneous addition OA and odorant, we
also note the possibility that enhanced stabilization (but not
trafficking) of ORx-ORco heteromers may also be a contributing
factor. This possibility should be formally addressed in future
studies.
A distinction between the two models described above, both
in terms of channel subunit stoichiometries and the nature
of the channel pore, should be feasible despite the current
lack of determined structures and the paucity of available
information in existing computational structure predictions
(Carraher et al., 2015; Hopf et al., 2015). For the stoichiometries
of ORco homomer and ORx/ORco heteromer subunits, cross-
linking studies should provide relevant clues, which could
be further tested by mutational studies to identify residues
critical for subunit interface interactions. For the issue of
the nature of the heteromeric channel, on the other hand,
differential labeling of ORco subunits with fluorescent tags
in positions that allow FRET/BRET to occur in the case of
homomer or heteromer channel pore formation (Machleidt
et al., 2015; Scott and Hoppe, 2015; Cranfill et al., 2016) may
prove informative. It is also hoped that the application of
new approaches to the efforts for structure determination of
membrane-anchored receptors including that of single-particle
cryo-EM (Baker et al., 2015; Eisenstein, 2016; Tajima et al.,
2016) will provide new insights allowing distinction between
the two alternatives of our working model and permutations
thereof.
Finally, implicit to these findings is the prediction that
should natural volatiles with OA-like properties similar to those
reported here exist, their use as enhancers of mosquito (and
other insect) odor recognition sensitivity could have practical
implications. Typical examples include enhanced trapping
applications relevant to population surveillance and improved
protection measures.
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